BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3124536)

  • 1. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A; Simon P
    Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
    Meyrier A; Condamin MC; Broneer D
    Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N; Hogan SL; Falk RJ
    Semin Nephrol; 2003 Mar; 23(2):229-33. PubMed ID: 12704583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(10):744-9. PubMed ID: 2687950
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine in glomerular disease.
    Mowry JA; McCarthy ET
    Semin Nephrol; 1996 Nov; 16(6):548-54. PubMed ID: 9125799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
    Brodehl J; Krohn HP; Ehrich JH
    Klin Padiatr; 1982; 194(3):162-5. PubMed ID: 6752557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.